Literature DB >> 19560616

[Chloroquine cardiotoxicity in long-term lupus therapy in two patients].

A Saussine1, M-A Loriot, C Picard, V Lecerf, J Landry, I Scheer, S Voicu, A Leenhardt, G Ducrocq, E Maubec, B Crickx.   

Abstract

BACKGROUND: The antimalarial compounds chloroquine and hydroxychloroquine are widely used in the treatment of connective tissue diseases and are usually well tolerated. We report two cases of chloroquine cardiotoxicity. PATIENTS AND METHODS: Two women (aged 43 and 48 years) were treated for 5 years for lupus. They developed severe conduction disturbances requiring a pacemaker. Plasma chloroquine concentrations were abnormally high in both cases. In one case, a genetic polymorphism modulating the activity of a cytochrome involved in chloroquine metabolism (CYP2C8) was identified. DISCUSSION: Since 1965, 60 cases of occasionally severe cardiotoxicity have been reported following long-term treatment with chloroquine in most cases, but also with hydroxychloroquine. This toxicity must be detected early and close cardiac assessment is required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560616     DOI: 10.1016/j.annder.2009.01.016

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  5 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Hydroxychloroquine-induced cardiomyopathy and heart failure in twins.

Authors:  Hang Zhao; Joyce Wald; Michael Palmer; Yuchi Han
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 3.  The COVID-19 pandemic: a threat to antimicrobial resistance containment.

Authors:  Raspail C Founou; Ariel J Blocker; Michel Noubom; Cedrice Tsayem; Siméon P Choukem; Maarten Van Dongen; Luria L Founou
Journal:  Future Sci OA       Date:  2021-06-10

4.  Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Authors:  A Nandagudi; E C Jury; D Alonzi; T D Butters; S Hughes; D A Isenberg
Journal:  Lupus       Date:  2013-07-17       Impact factor: 2.911

5.  Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.

Authors:  Serena Romani; Alexandre Gérard; Audrey Fresse; Delphine Viard; Élise Van-Obberghen; Joëlle Micallef; Fanny Rocher; Milou-Daniel Drici
Journal:  Clin Transl Sci       Date:  2020-10-23       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.